Table 1

Single-nucleotide polymorphisms included in the analysis, and results of analysis of covariance with Scale for the Assessment of Negative Symptoms scores

SNPChromosomePositionGeneRisk alleleReferenceF statisticp value
rs4765913122310730CACNA1CAPerlis et al.190.1110.74
rs108961351166783531C11orf80G0.8690.35
rs109943361060420054ANK3T2.0610.15
rs109943971060519366ANK3T3.0080.09
rs125767751179366149TENM4G1.1620.28
rs1006737122236129CACNA1CA0.0540.82
rs19385261060540625ANK3GZhang et al.200.490.49
rs736408352801338ITIH3CLi et al.212.4910.12
rs20706151248824388CACNB3G6.2020.014
rs21754201179412839TENM4T2.3540.13
rs217652821.94E+08N/AG1.3880.24
rs3774609353798876CACNA1DT0.0640.80
rs3845817265531391N/AT1.670.20
rs4660531141374150FOXO6T5.8540.017
rs6746896296745212N/AG0.530.47
rs72962881249086185N/AC0.1570.69
rs7578035298766429N/AG1.3630.25
rs98041901060080073ANK3C0.0150.90
rs111687511248825355CACNB3G0.4730.49
rs937160161.52E+08SYNE1T0.1180.73
rs110301011127659197BDNF, BDNF-ASTXu et al.220.4240.52
  • N/A = not applicable; SNP = single-nucleotide polymorphism.